Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$24.72 USD
-0.93 (-3.63%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $24.71 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-1.13 | 5.99% |
Earnings Summary
For their last quarter, Beam Therapeutics (BEAM) reported earnings of -$1.11 per share, beating the Zacks Consensus Estimate of $-1.13 per share. This reflects a positive earnings surprise of 1.77%. Look out for BEAM's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$1.13 per share, reflecting a year-over-year increase of 7.38%.
Earnings History
Price & Consensus
Zacks News for BEAM
CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?
BEAM: What are Zacks experts saying now?
Zacks Private Portfolio Services